Prostate Cancer: Ethnic Groups

The Department funded National Institute for Health and Care Research (NIHR) funds research and research infrastructure, which supports patients and the public to participate in high-quality research, including clinical research on prostate cancer. NIHR research expenditure for all cancers was £133 million in 2023/24, reflecting its high priority.

These investments are pivotal towards efforts to improve cancer prevention, treatment, and outcomes. The TRANSFORM trial is an important example of this. On 19 November 2023, the Government and Prostate Cancer UK announced the £42 million TRANSFORM screening trial to find the best way to screen men for prostate cancer, to find it before it becomes advanced and harder to treat.

Prostate Cancer UK is leading the development of the trial with the Government contributing £16 million through the Department. One of the aims of the trial is to address some of the inequalities that exist in prostate cancer diagnosis today. For example, one in four black men will develop prostate cancer, double the risk of other men, and often at a younger age. The trial will ensure that at least 10% of the men who are invited to participate in the trial are black.

The NIHR provides an online service called Be Part of Research, which promotes participation in health and social care research by allowing users to search for relevant studies and register their interest. This makes it easier for people to find and take part in health and care research that is relevant to them.

The NIHR continues to encourage and welcome applications for research into any aspect of human health, including prostate cancer.